EcoDrugPlus

Amyloid Beta Precursor Protein

Ensembl ID : ENSNBRG00000008868
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSNBRG00000014958
Gene Symbol: AR
3 Cross references
212 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSNBRG00000019644
Gene Symbol: LOC102795905
2 Cross references
206 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSNBRG00000017481
Gene Symbol: AGTR1
3 Cross references
198 Possible Orthologues:

Anti-Apoptotic Protein Nr13-Like

Ensembl ID : ENSNBRG00000011674
Gene Symbol: LOC102794833
3 Cross references
128 Possible Orthologues:

Antithrombin-Iii-Like

Ensembl ID : ENSNBRG00000003451
Gene Symbol: LOC102797582
3 Cross references
199 Possible Orthologues:

Apelin Receptor A-Like

Ensembl ID : ENSNBRG00000019156
Gene Symbol: LOC102777413
3 Cross references
171 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSNBRG00000013081
Gene Symbol: LOC102799495
2 Cross references
168 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type-Like

Ensembl ID : ENSNBRG00000002664
Gene Symbol: LOC102787244
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Activating Protein-Like

Ensembl ID : ENSNBRG00000014108
Gene Symbol: LOC102776613
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase-Like

Ensembl ID : ENSNBRG00000020869
Gene Symbol: LOC102797118
3 Cross references
225 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSNBRG00000013319
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).